MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women

Journal of Human Genetics

Volumn 54, Issue 7, 2009, Pages 414-418

  Gao, Chang Ming ^a   Tang, Jin Hai ^a   Cao, Hai Xia ^a   Ding, Jian Hua ^a   Wu, Jian Zhong ^a   Wang, Jie ^a   Liu, Yan Ting ^a   Li, Suu Ping ^a   Su, Ping ^a   Matsuo, Keitaro ^b   Takezaki, Toshiro ^c   Tajima, Kazuo ^b  

^a JIANGSU CANCER HOSPITAL   (China)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Breast cancer; Folate; Genetic polymorphisms; Methylenetetrahydrofolate reductase; Susceptibility

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CHINESE; CIGARETTE SMOKING; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENE FREQUENCY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INCOME; JOB CHARACTERISTICS; MAJOR CLINICAL STUDY; MENOPAUSE; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DIET; FEEDING BEHAVIOR; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 68449103543     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2009.57     Document Type: Article

References (45)

1. Kim, Y. I. Folate and carcinogenesis: evidence, mechanisms, and implications. J. Nutr. Biochem. 10, 66-88 (1999).
2. Mason, J. B. & Choi, S. W. Folate and carcinogenesis: developing a unifying hypothesis. Adv. Enzyme Regul. 40, 127-141 (2000).
3. Bailey, L. B. & Gregory, J. F. III Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J. Nutr. 129, 919-922 (1999).
4. Choi, S. W. & Mason, J. B. Folate and carcinogenesis: an integrated scheme. J. Nutr. 130, 129-132 (2000).
5. Fodinger, M., Horl, W. H. & Sunder-Plassmann, G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J. Nephrol. 13, 20-33 (2000).
6. Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G. et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenete-trahydrofolate reductase. Nat. Genet. 10, 111-113 (1995).
7. van der Put, N. M., Gabreels, F., Stevens, E. M., Smeitink, J. A., Trijbels, F. J., Eskes, T. K. et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am. J. Hum. Genet. 62, 1044-1051 (1998).
8. Weisberg, I., Tran, P., Christensen, B., Sibani, S. & Rozen, R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64, 169-172 (1998).
9. Thomas, P. & Fenech, M. Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitam. Horm. 79, 375-392 (2008).
10. Boccia, S., Hung, R., Ricciardi, G., Gianfagna, F., Ebert, M. P., Fang, J. Y. et al. Meta-and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am. J. Epidemiol. 167, 505-516 (2008).
11. Langsenlehner, T., Renner, W., Yazdani-Biuki, B. & Langsenlehner, U. Methylenete-trahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res. Treat. 107, 459-460 (2008).
12. Lewis, S. J., Harbord, R. M., Harris, R. & Smith, G. D. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J. Natl Cancer Inst. 98, 1607-1622 (2006).
13. Zintzaras, E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin. Genet. 69, 327-336 (2006).
14. Suzuki, T., Matsuo, K., Hirose, K., Hiraki, A., Kawase, T., Watanabe, M. et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 29, 356-362 (2008).
15. Macis, D., Maisonneuve, P., Johansson, H., Bonanni, B., Botteri, E., Iodice, S. et al. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. Breast Cancer Res. Treat. 106, 263-271 (2007).
16. Cao, H. X., Gao, C. M., Takezaki, T., Wu, J. Z., Ding, J. H., Liu, Y. T. et al. Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pac. J. Cancer Prev. 9, 203-208 (2008).
17. Gao, C., Wu, J., Ding, J., Liu, Y., Zang, Y., Li, S. et al. [Polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of stomach cancer]. Zhonghua Liu Xing Bing Xue Za Zhi. 23, 289-292 (2002).
18. Gao, C. M., Wu, J. Z., Liu, Y. T., Ding, J. H., Li, S. P., Su, P. et al. [Interactions between lifestyle, methylanetetrahydrofolate reductase gene and polymorphisms in thymidylate synthase gene with risk of stomach cancer]. Zhonghua Liu Xing Bing Xue Za Zhi. 24, 599-603 (2003).
19. Gao, C. M., Takezaki, T., Wu, J. Z., Liu, Y. T., Ding, J. H., Li, S. P. et al. Polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase genes and the susceptibility to esophageal and stomach cancer with smoking. Asian Pac. J. Cancer Prev. 5, 133-138 (2004).
20. Gao, C. M., Toshiro, T., Wu, J. Z., Cao, H. X., Liu, Y. T., Ding, J. H. et al. [A case-control study on the polymorphisms of methylenetetrahydrofolate reductase 1298 A→C and susceptibility of esophageal cancer]. Zhonghua Liu Xing Bing Xue Za Zhi. 25, 341-345 (2004).
21. Wang, Y. M., Mo, B. Q., Takezaki, T., Imaeda, N., Kimura, M., Wang, X. R. et al. Geographical variation in nutrient intake between urban and rural areas of Jiangsu province, China and development of a semi-quantitative food frequency questionnaire for middle-aged inhabitants. J. Epidemiol. 13, 80-89 (2003).
22. Yang, Y. X. China Food Composition 2004, 1ts edn. (Peking University Medical Press, Peking, 2005).
23. Semenza, J. C., Delfino, R. J., Ziogas, A. & Anton-Culver, H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res. Treat. 77, 217-223 (2003).
24. Chen, J., Gammon, M. D., Chan, W., Palomeque, C., Wetmur, J. G., Kabat, G. C. et al. One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res. 65, 1606-1614 (2005).
25. Stevens, V. L., McCullough, M. L., Pavluck, A. L., Talbot, J. T., Feigelson, H. S., Thun, M. J. et al. Association of polymorphisms in one-carbon metabolism genes and postmenopausal breast cancer incidence. Cancer Epidemiol. Biomarkers Prev. 16, 1140-1147 (2007).
26. Deligezer, U., Akisik, E. E. & Dalay, N. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In Vivo. 19, 889-893 (2005).
27. Ergul, E., Sazci, A., Utkan, Z. & Canturk, N. Z. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol. 24, 286-290 (2003).
28. Justenhoven, C., Hamann, U., Pierl, C. B., Rabstein, S., Pesch, B., Harth, V. et al. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol. Biomarkers Prev. 14, 3015-3018 (2005).
29. Grieu, F., Powell, B., Beilby, J. & Iacopetta, B. Methylenetetrahydrofolate reductase and thymidylate synthase polymorphisms are not associated with breast cancer risk or phenotype. Anticancer Res. 24, 3215-3219 (2004).
30. Kotsopoulos, J., Zhang, W. W., Zhang, S., McCready, D., Trudeau, M., Zhang, P. et al. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res. Treat. 112, 585-593 (2008).
31. Reljic, A., Simundic, A. M., Topic, E., Nikolac, N., Justinic, D. & Stefanovic, M. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin. Biochem. 40, 981-985 (2007).
32. Hekim, N., Ergen, A., Yaylim, I., Yilmaz, H., Zeybek, U., Ozturk, O. et al. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem. Funct. 25, 115-117 (2007).
33. Lissowska, J., Gaudet, M. M., Brinton, L. A., Chanock, S. J., Peplonska, B., Welch, R. et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int. J. Cancer 120, 2696-2703 (2007).
34. Kim, Y. I. Does a high folate intake increase the risk of breast cancer? Nutr. Rev. 64, 468-475 (2006).
35. Chou, Y. C., Wu, M. H., Yu, J. C., Lee, M. S., Yang, T., Shih, H. L. et al. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis 27, 2295-2300 (2006).
36. Brekelmans, C. T. Risk factors and risk reduction of breast and ovarian cancer. Curr. Opin. Obstet. Gynecol. 15, 63-68 (2003).
37. Zhang, S. M. Role of vitamins in the risk, prevention, and treatment of breast cancer. Curr. Opin. Obstet. Gynecol. 16, 19-25 (2004).
38. Shrubsole, M. J., Gao, Y. T., Cai, Q., Shu, X. O., Dai, Q., Hebert, J. R. et al. MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol. Biomarkers Prev. 13, 190-196 (2004).
39. Ericson, U., Sonestedt, E., Ivarsson, M. I., Gullberg, B., Carlson, J., Olsson, H. et al. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort. Cancer Epidemiol. Biomarkers Prev. 18, 1101-1110 (2009).
40. Yang, Q. H., Botto, L. D., Gallagher, M., Friedman, J. M., Sanders, C. L., Koontz, D. et al. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am. J. Clin. Nutr. 88, 232-246 (2008).
41. DeVos, L., Chanson, A., Liu, Z., Ciappio, E. D., Parnell, L. D., Mason, J. B. et al. Associations between single nucleotide polymorphisms in folate uptake and metabolizing genes with blood folate, homocysteine, and DNA uracil concentrations. Am. J. Clin. Nutr. 88, 1149-1158 (2008).
42. Chou, Y. C., Lee, M. S., Wu, M. H., Shih, H. L., Yang, T., Yu, C. P. et al. Plasma homocysteine as a metabolic risk factor for breast cancer: findings from a case-control study in Taiwan. Breast Cancer Res. Treat. 101, 199-205 (2007).
43. Sharp, L., Little, J., Schofield, A. C., Pavlidou, E., Cotton, S. C., Miedzybrodzka, Z. et al. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett. 181, 65-71 (2002).
44. Ulrich, C. M. Folate and cancer prevention: a closer look at a complex picture. Am. J. Clin. Nutr. 86, 271-273 (2007).
45. Stolzenberg-Solomon, R. Z., Chang, S. C., Leitzmann, M. F., Johnson, K. A., Johnson, C., Buys, S. S. et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am. J. Clin. Nutr. 83, 895-904 (2006).